US Customs Ruling (CROSS)
 HS Code : | | |
|---|
 HTS Code : | | |
|---|
Ruling Number :
Issuing Country : UNITED STATES
Date Of Issue : 2021-09-27T00:00:00
Fulvestrant Injection in dosage form
estrogen receptor antagonist
Fulvestrant Injection, imported in 250 mg/5 mL syringes, is an estrogen receptor antagonist. It is indicated for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy, as monotherapy or in combination with other antineoplastic agents.
Description : Fulvestrant Injection in dosage form
Please importantly note that only the relevant portion of the related US Ruling (Cross) is displayed above. You may refer to the said customs ruling for the entire ruling explanation.
Source : US Customs Ruling (CROSS)
source link :